Table 1.
Whey Protein Description | Experimental Detail | Outcome | Reference |
---|---|---|---|
ALPM (β-lactoglobulin 142-145AA) GDLE (β-lactoglobulin 52-55AA) VGIN (α-lactoalbumin 99-102AA) AVEGPK (BSA 568-573AA) |
Undifferentiated C2C12,-5 mM synthesized peptide pretreated for 1 h, 37 °C prior to ABAP radical (600 μM) | Each peptide ↓ % free radical formation similar to control V cells treated with ABAP treatment | [49] |
Wheylin-1 (MH), thermolysin hydrolysis β-lactoglobulin | Differentiated C2C12, 500 μM synthesized peptide for 3 h at 37 °C, plus insulin (100 nM) for 15 min | ↑ phosphorylated Akt: Akt total protein V cells treated with insulin alone or V saline | [50] |
Hydrolysed whey protein (COMBAT-MusclePharm, proprietary blend from whey protein concentrate) | Differentiated C2C12, 6 h treatment with 13 μg/mL | ↓ raptor mRNA V cells treated with DMEM media alone | [51] |
Sheep whey protein | Preincubated differentiated C2C12 cells with sheep whey protein for 24 h at 0.78 1.56, 3.12 and 6.24 mg/mL. Stressed with tBHP for 30 min | ↑ GSH, ↓ ROS with 1.56, 3.12 and 6.24 mg/mL V cells treated with tBHP alone | [53] |
Whey protein | Undifferentiated C2C12 whey protein (0.4 mg/mL) for 24 h and then stressed with 0.5 mM H2O2 | ↓ MDA V cells treated with H2O2 control ↑ GSH, SOD, CAT, G-Px V cells treated with H2O2 control |
[54] |
Ribonucelease5 enriched whey from bovine skim milk | Differentiated C2C12,10 μg/mL Ribonuclease 5 fractions that differed in purity, 4-day differentiation | ↑ myogenesis myosin heavy chain staining V cells treated with media alone ↑ creatine kinase activity similar to IGF-1 (200 ng/mL) positive control at 3 and 4 days V cells with media alone |
[55] |